Krishnan Suma bought KRYS
February 27, 2026 · Form 4 insider transaction
Krishnan Suma bought 4,000 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
InsiderKrishnan Suma
Role—
CompanyKrystal Biotech, Inc. (KRYS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after1,429,975
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
16,000 restricted stock units ("RSUs") were granted on February 28, 2025. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period with the first installment, or 4,000 RSUs, vesting on February 27, 2026.